Revance Therapeutics, Inc.: SCHEDULE 13G filed Feb 11, 2025

Form type

SCHEDULE 13G

Filing date

Feb 11, 2025

Accession number

0000019617-25-000200

Filer

Revance Therapeutics, Inc. (CIK 1479290)